Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,723,406
-$2,836,419 QoQ
Shares Held
1,095,251
+6.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. SNY ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,723,406 | 1,095,251 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,559,825 | 1,028,639 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,767,152 | 923,796 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $45,917,481 | 972,828 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $40,374,114 | 835,730 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $48,573,696 | 875,833 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,095,332 | 810,602 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,843,717 | 656,667 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,398,100 | 399,796 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,902,252 | 347,783 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,054,290 | 182,069 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,155,456 | 207,969 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,587,306 | 344,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,541,949 | 359,095 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $14,403,032 | 297,399 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,886,457 | 312,637 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,094,800 | 301,715 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,170,454 | 276,012 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,660,468 | 252,704 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,196,779 | 190,765 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,848,579 | 338,940 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,251,335 | 308,357 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,944,321 | 328,140 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,442,953 | 347,677 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,911,550 | 292,097 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,248,981 | 394,533 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||